HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Endocarditis due to ampicillin-resistant nontyphoid Salmonella: cure with a third-generation cephalosporin.

Abstract
A case of ampicillin-resistant salmonella bacteremia complicated by endocarditis in a 78-year-old man is presented. Previous rheumatic valvular heart disease and the lack of response to initial treatment with chloramphenicol prompted us to consider this diagnosis. There was a good clinical response after treatment with ceftriaxone alone and corresponding improvement on the echocardiogram. This case demonstrates the possible endovascular complications of salmonella bacteremia in elderly people and that endocarditis should be included among the invasive infections due to ampicillin-resistant Salmonella that could potentially be treated with the newer cephalosporins.
AuthorsC Rodriguez, M T Olcoz, G Izquierdo, S Moreno
JournalReviews of infectious diseases (Rev Infect Dis) 1990 Sep-Oct Vol. 12 Issue 5 Pg. 817-9 ISSN: 0162-0886 [Print] United States
PMID2237123 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Chloramphenicol
  • Ceftriaxone
Topics
  • Aged
  • Ampicillin Resistance
  • Ceftriaxone (therapeutic use)
  • Chloramphenicol (therapeutic use)
  • Endocarditis, Bacterial (drug therapy, etiology)
  • Follow-Up Studies
  • Heart Valve Diseases (complications)
  • Humans
  • Male
  • Rheumatic Heart Disease (complications)
  • Salmonella Infections (drug therapy, etiology)
  • Salmonella enteritidis (drug effects, isolation & purification)
  • Sepsis (complications)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: